Investor Relations
Latest Financial Results
Q3 2024 Quarterly Results
Quarter Ended Sep 30, 2024
Quarter Ended Sep 30, 2024
Maravai Corporate Presentation
Jefferies London Healthcare Conference
Quarter Ended Sep 30, 2024
For fiscal year ending Dec 31, 2023
Sign up today and receive company updates straight to your inbox.
Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support research on human diseases. Our customers include top global biopharmaceutical companies and many other emerging biopharmaceutical and life sciences research companies, as well as leading academic research institutions and in vitro diagnostics companies. Our products address the key phases of biopharmaceutical development spanning research to commercialization and include complex nucleic acids for vaccine, therapeutic and diagnostic applications, custom enzymes for research and diagnostic use and antibody-based products to detect impurities during the production of biopharmaceutical products. We provide products that support our customers from discovery through commercialization of their vaccines, therapeutic agents and in vitro diagnostic products. Our products are offered under the following brands:
Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV®, Sterling™, Glen Pak™, Glen Gel-Pak™, and Poly-Pak™.
Maravai's portfolio companies are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications.
Maravai LifeSciences Holdings, Inc.
10770 Wateridge Circle
Suite 200
San Diego, CA 92121
United States
ir@maravai.com
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
United States
helpAST@equiniti.com
https://equiniti.com/us/ast-access/individuals/